The analysis of urinary eicosanoids in patients with controlled aspirin exacerbated respiratory disease (AERD)

The analysis of urinary eicosanoids in patients with controlled aspirin exacerbated respiratory disease (AERD) - The analysis of urinary eicosanoids in patients with controlled AERD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019561

Enrollment

200

Registered

2015-11-02

Start date

2015-10-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin exacerbated respiratory disease (AERD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with AERD or non-AERD by a systemic aspirin provocation test within the last fifteen years 2)Patients evaluated as controlled asthma

Exclusion criteria

Exclusion criteria: Patients considered unsuitable by the attending physician

Design outcomes

Primary

Measure	Time frame
Differences in eicosanoids between AERD and non-AERD	—

Countries

Japan

Contacts

Public ContactYosuke Kamide

Sagamihara National Hospital Clinical Research Center for Allergy and Rheumatology

m08702012@gmail.com042-742-8311

Outcome results